

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | motile cilium assembly (GO:0044458) | 8.50401553 |
| 2 | cilium movement (GO:0003341) | 8.35309777 |
| 3 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 7.49352007 |
| 4 | epithelial cilium movement (GO:0003351) | 6.87011631 |
| 5 | protoporphyrinogen IX metabolic process (GO:0046501) | 5.61849010 |
| 6 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 5.35714352 |
| 7 | axoneme assembly (GO:0035082) | 5.24842284 |
| 8 | tolerance induction (GO:0002507) | 4.66230449 |
| 9 | left/right pattern formation (GO:0060972) | 4.65782808 |
| 10 | response to peptidoglycan (GO:0032494) | 4.53286088 |
| 11 | positive regulation of tolerance induction (GO:0002645) | 4.34407505 |
| 12 | sodium ion export (GO:0071436) | 4.34086087 |
| 13 | cellular potassium ion homeostasis (GO:0030007) | 4.24387276 |
| 14 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 4.24054060 |
| 15 | negative regulation of B cell mediated immunity (GO:0002713) | 4.24054060 |
| 16 | detection of other organism (GO:0098543) | 4.21810308 |
| 17 | response to xenobiotic stimulus (GO:0009410) | 4.17423944 |
| 18 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.12540936 |
| 19 | porphyrin-containing compound biosynthetic process (GO:0006779) | 4.12151767 |
| 20 | detection of molecule of bacterial origin (GO:0032490) | 4.05852942 |
| 21 | heme biosynthetic process (GO:0006783) | 4.02782530 |
| 22 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 4.00860148 |
| 23 | regulation of tolerance induction (GO:0002643) | 3.99575373 |
| 24 | aminoglycoside antibiotic metabolic process (GO:0030647) | 3.96064394 |
| 25 | ventricular system development (GO:0021591) | 3.93944881 |
| 26 | detection of bacterium (GO:0016045) | 3.92390270 |
| 27 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 3.91570658 |
| 28 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.91373602 |
| 29 | cellular extravasation (GO:0045123) | 3.82049573 |
| 30 | negative regulation of humoral immune response (GO:0002921) | 3.81988427 |
| 31 | detection of external biotic stimulus (GO:0098581) | 3.81936957 |
| 32 | macrophage activation involved in immune response (GO:0002281) | 3.78996995 |
| 33 | regulation of cilium movement (GO:0003352) | 3.76442046 |
| 34 | negative regulation of cell killing (GO:0031342) | 3.72209935 |
| 35 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.72209935 |
| 36 | regulation of germinal center formation (GO:0002634) | 3.71647315 |
| 37 | tetrapyrrole biosynthetic process (GO:0033014) | 3.70990415 |
| 38 | lysine metabolic process (GO:0006553) | 3.66650980 |
| 39 | lysine catabolic process (GO:0006554) | 3.66650980 |
| 40 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.63172205 |
| 41 | primary alcohol catabolic process (GO:0034310) | 3.61071135 |
| 42 | gas transport (GO:0015669) | 3.60292436 |
| 43 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.59955909 |
| 44 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.57054284 |
| 45 | left/right axis specification (GO:0070986) | 3.56343905 |
| 46 | low-density lipoprotein particle remodeling (GO:0034374) | 3.55806743 |
| 47 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.51012422 |
| 48 | oxygen transport (GO:0015671) | 3.49631406 |
| 49 | heme metabolic process (GO:0042168) | 3.46893605 |
| 50 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.45697894 |
| 51 | regulation of interleukin-6 biosynthetic process (GO:0045408) | 3.45042030 |
| 52 | urate metabolic process (GO:0046415) | 3.44158876 |
| 53 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.43456577 |
| 54 | hypotonic response (GO:0006971) | 3.42554500 |
| 55 | porphyrin-containing compound metabolic process (GO:0006778) | 3.42535862 |
| 56 | cysteine metabolic process (GO:0006534) | 3.42473744 |
| 57 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.34642358 |
| 58 | vitamin transmembrane transport (GO:0035461) | 3.31959277 |
| 59 | neutrophil mediated immunity (GO:0002446) | 3.31678373 |
| 60 | drug transmembrane transport (GO:0006855) | 3.30998637 |
| 61 | macrophage activation (GO:0042116) | 3.30641350 |
| 62 | negative regulation of interleukin-12 production (GO:0032695) | 3.29756703 |
| 63 | low-density lipoprotein particle clearance (GO:0034383) | 3.28561032 |
| 64 | detection of biotic stimulus (GO:0009595) | 3.28173742 |
| 65 | diterpenoid biosynthetic process (GO:0016102) | 3.27655401 |
| 66 | drug transport (GO:0015893) | 3.25437818 |
| 67 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.23451022 |
| 68 | microglial cell activation (GO:0001774) | 3.22002781 |
| 69 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.20725201 |
| 70 | myeloid leukocyte mediated immunity (GO:0002444) | 3.19859550 |
| 71 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.18705219 |
| 72 | valine metabolic process (GO:0006573) | 3.15508072 |
| 73 | nonribosomal peptide biosynthetic process (GO:0019184) | 3.15185656 |
| 74 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.09856233 |
| 75 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.09856233 |
| 76 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.09742457 |
| 77 | glutathione biosynthetic process (GO:0006750) | 3.09269027 |
| 78 | ethanol metabolic process (GO:0006067) | 3.07300956 |
| 79 | regulation of response to osmotic stress (GO:0047484) | 3.05498064 |
| 80 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.04935166 |
| 81 | germinal center formation (GO:0002467) | 3.04709656 |
| 82 | alanine transport (GO:0032328) | 3.01554371 |
| 83 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.01226348 |
| 84 | response to host immune response (GO:0052572) | 3.01226348 |
| 85 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 3.00706973 |
| 86 | neutrophil activation (GO:0042119) | 3.00323492 |
| 87 | response to methylmercury (GO:0051597) | 2.99443687 |
| 88 | regulation of interleukin-5 production (GO:0032674) | 2.97106570 |
| 89 | neutrophil activation involved in immune response (GO:0002283) | 2.96991988 |
| 90 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.94459132 |
| 91 | microtubule bundle formation (GO:0001578) | 2.94255819 |
| 92 | response to thyroid hormone (GO:0097066) | 2.93559488 |
| 93 | reactive oxygen species biosynthetic process (GO:1903409) | 2.92670382 |
| 94 | negative regulation of adaptive immune response (GO:0002820) | 2.92181153 |
| 95 | response to host (GO:0075136) | 2.91980440 |
| 96 | response to host defenses (GO:0052200) | 2.91980440 |
| 97 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.91980440 |
| 98 | regulation of toll-like receptor 4 signaling pathway (GO:0034143) | 2.88404717 |
| 99 | negative regulation of interleukin-6 production (GO:0032715) | 2.87802375 |
| 100 | glycoside metabolic process (GO:0016137) | 2.87713370 |
| 101 | plasma lipoprotein particle organization (GO:0071827) | 2.84885562 |
| 102 | immunoglobulin mediated immune response (GO:0016064) | 2.84689970 |
| 103 | regulation of mast cell degranulation (GO:0043304) | 2.84579535 |
| 104 | regulation of gamma-delta T cell activation (GO:0046643) | 2.81814768 |
| 105 | phosphate ion transport (GO:0006817) | 2.80941918 |
| 106 | granulocyte activation (GO:0036230) | 2.80173412 |
| 107 | cellular sodium ion homeostasis (GO:0006883) | 2.79507263 |
| 108 | positive regulation of p38MAPK cascade (GO:1900745) | 2.79110030 |
| 109 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.78237957 |
| 110 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.76966034 |
| 111 | potassium ion import (GO:0010107) | 2.76256673 |
| 112 | toxin transport (GO:1901998) | 2.75370996 |
| 113 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.75366194 |
| 114 | L-amino acid import (GO:0043092) | 2.73607300 |
| 115 | positive regulation of extracellular matrix organization (GO:1903055) | 2.72595359 |
| 116 | regulation of cellular amide metabolic process (GO:0034248) | 2.71971755 |
| 117 | phosphate ion transmembrane transport (GO:0035435) | 2.71943526 |
| 118 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.71137883 |
| 119 | protein-lipid complex subunit organization (GO:0071825) | 2.69436979 |
| 120 | plasma lipoprotein particle assembly (GO:0034377) | 2.69091929 |
| 121 | hemoglobin metabolic process (GO:0020027) | 2.68140281 |
| 122 | regulation of toll-like receptor signaling pathway (GO:0034121) | 2.67397490 |
| 123 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.67096223 |
| 124 | regulation of beta-amyloid formation (GO:1902003) | 2.67060603 |
| 125 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.66875962 |
| 126 | leukocyte aggregation (GO:0070486) | 2.65779073 |
| 127 | tetrapyrrole metabolic process (GO:0033013) | 2.63780578 |
| 128 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.63449480 |
| 129 | hydrogen peroxide catabolic process (GO:0042744) | 2.62412418 |
| 130 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.61372480 |
| 131 | regulation of leukocyte degranulation (GO:0043300) | 2.61059073 |
| 132 | superoxide anion generation (GO:0042554) | 2.60075297 |
| 133 | respiratory burst (GO:0045730) | 2.59102337 |
| 134 | fructose metabolic process (GO:0006000) | 2.58070025 |
| 135 | angiotensin maturation (GO:0002003) | 2.57159552 |
| 136 | myeloid cell activation involved in immune response (GO:0002275) | 2.56784668 |
| 137 | C4-dicarboxylate transport (GO:0015740) | 2.55813338 |
| 138 | response to type I interferon (GO:0034340) | 2.55359233 |
| 139 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.54447170 |
| 140 | glutamate metabolic process (GO:0006536) | 2.53315312 |
| 141 | drug catabolic process (GO:0042737) | 2.52276892 |
| 142 | response to lead ion (GO:0010288) | 2.50558910 |
| 143 | desmosome organization (GO:0002934) | 2.49370885 |
| 144 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.47689521 |
| 145 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.47296125 |
| 146 | * organic cation transport (GO:0015695) | 2.47121973 |
| 147 | positive regulation by symbiont of host defense response (GO:0052509) | 2.46565295 |
| 148 | modulation by symbiont of host defense response (GO:0052031) | 2.46565295 |
| 149 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.46565295 |
| 150 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.46565295 |
| 151 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.46565295 |
| 152 | modulation by symbiont of host immune response (GO:0052553) | 2.46565295 |
| 153 | short-chain fatty acid metabolic process (GO:0046459) | 2.46386033 |
| 154 | protein-lipid complex assembly (GO:0065005) | 2.44240885 |
| 155 | response to phenylpropanoid (GO:0080184) | 2.43993393 |
| 156 | plasma lipoprotein particle remodeling (GO:0034369) | 2.43747631 |
| 157 | protein-lipid complex remodeling (GO:0034368) | 2.43747631 |
| 158 | macromolecular complex remodeling (GO:0034367) | 2.43747631 |
| 159 | amino acid import (GO:0043090) | 2.43240666 |
| 160 | cellular modified amino acid catabolic process (GO:0042219) | 2.42636635 |
| 161 | renal absorption (GO:0070293) | 2.42019485 |
| 162 | regulation of hypersensitivity (GO:0002883) | 2.41652480 |
| 163 | bicarbonate transport (GO:0015701) | 2.41509126 |
| 164 | negative regulation of growth of symbiont in host (GO:0044130) | 2.39207280 |
| 165 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 2.39207280 |
| 166 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 2.39207280 |
| 167 | regulation of growth of symbiont in host (GO:0044126) | 2.39207280 |
| 168 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.38692096 |
| 169 | disruption of cells of other organism (GO:0044364) | 2.38245598 |
| 170 | killing of cells of other organism (GO:0031640) | 2.38245598 |
| 171 | gamma-aminobutyric acid transport (GO:0015812) | 2.37534168 |
| 172 | exogenous drug catabolic process (GO:0042738) | 2.36064586 |
| 173 | iron ion import (GO:0097286) | 2.35991005 |
| 174 | alpha-linolenic acid metabolic process (GO:0036109) | 2.35794709 |
| 175 | one-carbon compound transport (GO:0019755) | 2.34694501 |
| 176 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.34466812 |
| 177 | aspartate family amino acid catabolic process (GO:0009068) | 2.33474349 |
| 178 | glycine transport (GO:0015816) | 2.33408599 |
| 179 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.33371571 |
| 180 | regulation of triglyceride catabolic process (GO:0010896) | 2.32906026 |
| 181 | * carnitine metabolic process (GO:0009437) | 2.32094884 |
| 182 | tricarboxylic acid metabolic process (GO:0072350) | 2.31633261 |
| 183 | potassium ion homeostasis (GO:0055075) | 2.31617814 |
| 184 | axonemal dynein complex assembly (GO:0070286) | 11.9574733 |
| 185 | cilium or flagellum-dependent cell motility (GO:0001539) | 10.5689672 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 6.41344347 |
| 2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.91027860 |
| 3 | GATA1_22025678_ChIP-Seq_K562_Human | 3.52132234 |
| 4 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.24472612 |
| 5 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.99683062 |
| 6 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.54408676 |
| 7 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.52731250 |
| 8 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.46253887 |
| 9 | GATA1_19941826_ChIP-Seq_K562_Human | 2.38123232 |
| 10 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.33151707 |
| 11 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.30574594 |
| 12 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.27203277 |
| 13 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.23152435 |
| 14 | SPI1_23127762_ChIP-Seq_K562_Human | 2.21443184 |
| 15 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.15838464 |
| 16 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.05999676 |
| 17 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.03396732 |
| 18 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.98223288 |
| 19 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.96278733 |
| 20 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.94355483 |
| 21 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.92848868 |
| 22 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.91317876 |
| 23 | MAF_26560356_Chip-Seq_TH1_Human | 1.90655420 |
| 24 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.88375584 |
| 25 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.88189621 |
| 26 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.84932478 |
| 27 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.83163038 |
| 28 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.82935196 |
| 29 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.81950074 |
| 30 | GATA2_19941826_ChIP-Seq_K562_Human | 1.78384531 |
| 31 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 1.77893721 |
| 32 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.75792573 |
| 33 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.70712036 |
| 34 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.68532968 |
| 35 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.67202925 |
| 36 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.65641995 |
| 37 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.60963708 |
| 38 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.59806217 |
| 39 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.59758405 |
| 40 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.56961256 |
| 41 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.54889182 |
| 42 | MYB_26560356_Chip-Seq_TH2_Human | 1.54690451 |
| 43 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.54464751 |
| 44 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.53106379 |
| 45 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.53081181 |
| 46 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.52010719 |
| 47 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.50601230 |
| 48 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.50600439 |
| 49 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.50038152 |
| 50 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.49220637 |
| 51 | UTX_26944678_Chip-Seq_JUKART_Human | 1.47564227 |
| 52 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.46868789 |
| 53 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.46354236 |
| 54 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.45557125 |
| 55 | RXR_22108803_ChIP-Seq_LS180_Human | 1.44716957 |
| 56 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.43920536 |
| 57 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.43669146 |
| 58 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.42774444 |
| 59 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.40908877 |
| 60 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.40243271 |
| 61 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.39571247 |
| 62 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.39127052 |
| 63 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.38412867 |
| 64 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.38154608 |
| 65 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.37971854 |
| 66 | MYB_26560356_Chip-Seq_TH1_Human | 1.37827466 |
| 67 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.36771447 |
| 68 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.36598186 |
| 69 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.35244641 |
| 70 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.35072729 |
| 71 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.34050639 |
| 72 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.32611296 |
| 73 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.32294328 |
| 74 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.32287721 |
| 75 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.31884332 |
| 76 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.31119742 |
| 77 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.29544961 |
| 78 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.29237128 |
| 79 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.28433075 |
| 80 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.26573827 |
| 81 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.25867887 |
| 82 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.25844641 |
| 83 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.25355234 |
| 84 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.25211218 |
| 85 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.24000101 |
| 86 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.23020276 |
| 87 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.22637403 |
| 88 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.22468631 |
| 89 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.22468631 |
| 90 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.22275021 |
| 91 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.22163203 |
| 92 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.20405746 |
| 93 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.20230712 |
| 94 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.19657609 |
| 95 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.19394505 |
| 96 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.18641132 |
| 97 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.18120957 |
| 98 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.16184831 |
| 99 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.14915104 |
| 100 | MAF_26560356_Chip-Seq_TH2_Human | 1.14812005 |
| 101 | CJUN_26792858_Chip-Seq_BT549_Human | 1.14770049 |
| 102 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.13403277 |
| 103 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.12445583 |
| 104 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.11924905 |
| 105 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.10676663 |
| 106 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.09997873 |
| 107 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.09720843 |
| 108 | * SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.08134980 |
| 109 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.05974905 |
| 110 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.05215737 |
| 111 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.04158295 |
| 112 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.04047172 |
| 113 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.03964907 |
| 114 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.02264429 |
| 115 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.02139502 |
| 116 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.02009794 |
| 117 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.00473062 |
| 118 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.00387824 |
| 119 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.99704444 |
| 120 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.99368602 |
| 121 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.99363042 |
| 122 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.98486439 |
| 123 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.97977904 |
| 124 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.97918701 |
| 125 | P68_20966046_ChIP-Seq_HELA_Human | 0.97711658 |
| 126 | GATA3_26560356_Chip-Seq_TH2_Human | 0.96982824 |
| 127 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.96858237 |
| 128 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.96503653 |
| 129 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.96461395 |
| 130 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.94975829 |
| 131 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.94658110 |
| 132 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.93168787 |
| 133 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.92463376 |
| 134 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.92401580 |
| 135 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.91939998 |
| 136 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.90985276 |
| 137 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.89608638 |
| 138 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.88222469 |
| 139 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.87251075 |
| 140 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.87092360 |
| 141 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.85238737 |
| 142 | TP53_16413492_ChIP-PET_HCT116_Human | 0.85075743 |
| 143 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.85064612 |
| 144 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.85064612 |
| 145 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.84866579 |
| 146 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.84228341 |
| 147 | KDM2B_26808549_Chip-Seq_K562_Human | 0.83343271 |
| 148 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.83209591 |
| 149 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.82278825 |
| 150 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.81897820 |
| 151 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.79533563 |
| 152 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.79422209 |
| 153 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.79408510 |
| 154 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.78643811 |
| 155 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.78420412 |
| 156 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.75938549 |
| 157 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.75171940 |
| 158 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.74472411 |
| 159 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.74237936 |
| 160 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.74237936 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003656_abnormal_erythrocyte_physiolo | 4.74809160 |
| 2 | MP0005360_urolithiasis | 4.31732471 |
| 3 | MP0002132_abnormal_respiratory_system | 4.19166364 |
| 4 | MP0004147_increased_porphyrin_level | 3.82922524 |
| 5 | MP0002254_reproductive_system_inflammat | 2.95829726 |
| 6 | MP0002653_abnormal_ependyma_morphology | 2.68440762 |
| 7 | MP0002277_abnormal_respiratory_mucosa | 2.63157227 |
| 8 | MP0003436_decreased_susceptibility_to | 2.48382658 |
| 9 | MP0002139_abnormal_hepatobiliary_system | 2.46102512 |
| 10 | MP0004043_abnormal_pH_regulation | 2.33138796 |
| 11 | MP0003690_abnormal_glial_cell | 2.25179358 |
| 12 | MP0003646_muscle_fatigue | 2.21017435 |
| 13 | MP0006082_CNS_inflammation | 2.20704290 |
| 14 | MP0003191_abnormal_cellular_cholesterol | 2.09026466 |
| 15 | MP0002796_impaired_skin_barrier | 2.08822303 |
| 16 | MP0005332_abnormal_amino_acid | 2.05866418 |
| 17 | MP0009046_muscle_twitch | 2.05207079 |
| 18 | MP0010155_abnormal_intestine_physiology | 2.04008062 |
| 19 | MP0008260_abnormal_autophagy | 2.03975200 |
| 20 | MP0001853_heart_inflammation | 1.94179318 |
| 21 | MP0009278_abnormal_bone_marrow | 1.92813829 |
| 22 | MP0002405_respiratory_system_inflammati | 1.91959869 |
| 23 | MP0003075_altered_response_to | 1.83898342 |
| 24 | MP0004019_abnormal_vitamin_homeostasis | 1.80374139 |
| 25 | MP0003828_pulmonary_edema | 1.80223851 |
| 26 | MP0001545_abnormal_hematopoietic_system | 1.78266979 |
| 27 | MP0003186_abnormal_redox_activity | 1.76919526 |
| 28 | MP0004858_abnormal_nervous_system | 1.76219174 |
| 29 | MP0003195_calcinosis | 1.76058386 |
| 30 | MP0001765_abnormal_ion_homeostasis | 1.74801127 |
| 31 | MP0009764_decreased_sensitivity_to | 1.74188096 |
| 32 | MP0001800_abnormal_humoral_immune | 1.72214865 |
| 33 | MP0005636_abnormal_mineral_homeostasis | 1.71164994 |
| 34 | MP0002723_abnormal_immune_serum | 1.68068558 |
| 35 | MP0000465_gastrointestinal_hemorrhage | 1.67449531 |
| 36 | MP0002420_abnormal_adaptive_immunity | 1.67211349 |
| 37 | MP0002452_abnormal_antigen_presenting | 1.67161577 |
| 38 | MP0005083_abnormal_biliary_tract | 1.67039150 |
| 39 | MP0001819_abnormal_immune_cell | 1.65947427 |
| 40 | MP0002419_abnormal_innate_immunity | 1.65270194 |
| 41 | MP0000604_amyloidosis | 1.64829833 |
| 42 | MP0009643_abnormal_urine_homeostasis | 1.60780329 |
| 43 | MP0005058_abnormal_lysosome_morphology | 1.55036027 |
| 44 | MP0003329_amyloid_beta_deposits | 1.54019301 |
| 45 | MP0004883_abnormal_blood_vessel | 1.48748651 |
| 46 | MP0010329_abnormal_lipoprotein_level | 1.44142722 |
| 47 | MP0009840_abnormal_foam_cell | 1.42342070 |
| 48 | MP0000858_altered_metastatic_potential | 1.41866071 |
| 49 | MP0003806_abnormal_nucleotide_metabolis | 1.40593781 |
| 50 | MP0003183_abnormal_peptide_metabolism | 1.38918423 |
| 51 | MP0005167_abnormal_blood-brain_barrier | 1.38221422 |
| 52 | MP0005451_abnormal_body_composition | 1.37931832 |
| 53 | MP0002136_abnormal_kidney_physiology | 1.36887672 |
| 54 | MP0003172_abnormal_lysosome_physiology | 1.36222715 |
| 55 | MP0008875_abnormal_xenobiotic_pharmacok | 1.35951638 |
| 56 | MP0003303_peritoneal_inflammation | 1.35476670 |
| 57 | MP0003866_abnormal_defecation | 1.34016842 |
| 58 | MP0004885_abnormal_endolymph | 1.33863802 |
| 59 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.33623691 |
| 60 | MP0001533_abnormal_skeleton_physiology | 1.32090425 |
| 61 | MP0005501_abnormal_skin_physiology | 1.32047667 |
| 62 | MP0002148_abnormal_hypersensitivity_rea | 1.32015337 |
| 63 | MP0000343_altered_response_to | 1.31411512 |
| 64 | MP0001501_abnormal_sleep_pattern | 1.30668568 |
| 65 | MP0001756_abnormal_urination | 1.28921501 |
| 66 | MP0005671_abnormal_response_to | 1.27359382 |
| 67 | MP0009785_altered_susceptibility_to | 1.25035063 |
| 68 | MP0008004_abnormal_stomach_pH | 1.24887059 |
| 69 | MP0005025_abnormal_response_to | 1.23287942 |
| 70 | MP0001835_abnormal_antigen_presentation | 1.22962530 |
| 71 | MP0002398_abnormal_bone_marrow | 1.20085918 |
| 72 | MP0005535_abnormal_body_temperature | 1.18646629 |
| 73 | MP0000716_abnormal_immune_system | 1.18362901 |
| 74 | MP0003763_abnormal_thymus_physiology | 1.17186359 |
| 75 | MP0001851_eye_inflammation | 1.16624710 |
| 76 | MP0004381_abnormal_hair_follicle | 1.16474017 |
| 77 | MP0002089_abnormal_postnatal_growth/wei | 1.16243757 |
| 78 | MP0003300_gastrointestinal_ulcer | 1.14033997 |
| 79 | MP0009333_abnormal_splenocyte_physiolog | 1.12762430 |
| 80 | MP0002722_abnormal_immune_system | 1.11942840 |
| 81 | MP0005164_abnormal_response_to | 1.11819644 |
| 82 | MP0002998_abnormal_bone_remodeling | 1.10340572 |
| 83 | MP0002138_abnormal_hepatobiliary_system | 1.10298344 |
| 84 | MP0005166_decreased_susceptibility_to | 1.09684724 |
| 85 | MP0002006_tumorigenesis | 1.08057482 |
| 86 | MP0002060_abnormal_skin_morphology | 1.07487263 |
| 87 | MP0003724_increased_susceptibility_to | 1.06829998 |
| 88 | MP0002332_abnormal_exercise_endurance | 1.05028111 |
| 89 | MP0002166_altered_tumor_susceptibility | 1.04638711 |
| 90 | MP0002971_abnormal_brown_adipose | 1.03287891 |
| 91 | MP0005464_abnormal_platelet_physiology | 1.03197189 |
| 92 | MP0001216_abnormal_epidermal_layer | 1.02943961 |
| 93 | MP0003566_abnormal_cell_adhesion | 1.02713683 |
| 94 | MP0004947_skin_inflammation | 1.00918608 |
| 95 | MP0005000_abnormal_immune_tolerance | 1.00834871 |
| 96 | MP0010771_integument_phenotype | 0.99803698 |
| 97 | MP0009765_abnormal_xenobiotic_induced | 0.99801176 |
| 98 | MP0002429_abnormal_blood_cell | 0.99463708 |
| 99 | MP0002168_other_aberrant_phenotype | 0.99303309 |
| 100 | MP0002118_abnormal_lipid_homeostasis | 0.99203095 |
| 101 | MP0008569_lethality_at_weaning | 0.98954516 |
| 102 | MP0000689_abnormal_spleen_morphology | 0.98554600 |
| 103 | MP0005310_abnormal_salivary_gland | 0.97718382 |
| 104 | MP0005319_abnormal_enzyme/_coenzyme | 0.97044431 |
| 105 | MP0002933_joint_inflammation | 0.94671069 |
| 106 | MP0000685_abnormal_immune_system | 0.93370090 |
| 107 | MP0001958_emphysema | 0.93118261 |
| 108 | MP0001790_abnormal_immune_system | 0.92296819 |
| 109 | MP0005387_immune_system_phenotype | 0.92296819 |
| 110 | MP0008469_abnormal_protein_level | 0.91877682 |
| 111 | MP0002638_abnormal_pupillary_reflex | 0.90772554 |
| 112 | MP0001663_abnormal_digestive_system | 0.89461963 |
| 113 | MP0009780_abnormal_chondrocyte_physiolo | 0.87984738 |
| 114 | MP0005076_abnormal_cell_differentiation | 0.87890189 |
| 115 | MP0005390_skeleton_phenotype | 0.85619502 |
| 116 | MP0003045_fibrosis | 0.85562521 |
| 117 | MP0002009_preneoplasia | 0.85456832 |
| 118 | MP0003638_abnormal_response/metabolism_ | 0.84150593 |
| 119 | MP0000609_abnormal_liver_physiology | 0.83085577 |
| 120 | MP0005365_abnormal_bile_salt | 0.83075877 |
| 121 | MP0003453_abnormal_keratinocyte_physiol | 0.83047510 |
| 122 | MP0009931_abnormal_skin_appearance | 0.82839643 |
| 123 | MP0001845_abnormal_inflammatory_respons | 0.80936943 |
| 124 | MP0000249_abnormal_blood_vessel | 0.80688447 |
| 125 | MP0005623_abnormal_meninges_morphology | 0.80196760 |
| 126 | MP0003252_abnormal_bile_duct | 0.80168276 |
| 127 | MP0003091_abnormal_cell_migration | 0.80029202 |
| 128 | MP0005377_hearing/vestibular/ear_phenot | 0.79030003 |
| 129 | MP0003878_abnormal_ear_physiology | 0.79030003 |
| 130 | MP0004808_abnormal_hematopoietic_stem | 0.78674005 |
| 131 | MP0003633_abnormal_nervous_system | 0.76929376 |
| 132 | MP0005670_abnormal_white_adipose | 0.76417048 |
| 133 | MP0005376_homeostasis/metabolism_phenot | 0.76367436 |
| 134 | MP0000383_abnormal_hair_follicle | 0.76314675 |
| 135 | MP0004742_abnormal_vestibular_system | 0.75923735 |
| 136 | MP0003448_altered_tumor_morphology | 0.75561238 |
| 137 | MP0005174_abnormal_tail_pigmentation | 0.75305447 |
| 138 | MP0005165_increased_susceptibility_to | 0.75287343 |
| 139 | MP0009763_increased_sensitivity_to | 0.74369681 |
| 140 | MP0000920_abnormal_myelination | 0.74025616 |
| 141 | MP0004264_abnormal_extraembryonic_tissu | 0.73070716 |
| 142 | MP0001764_abnormal_homeostasis | 0.72708546 |
| 143 | MP0000678_abnormal_parathyroid_gland | 0.71571351 |
| 144 | MP0005666_abnormal_adipose_tissue | 0.71043633 |
| 145 | MP0005397_hematopoietic_system_phenotyp | 0.70905178 |
| 146 | MP0004510_myositis | 0.70300741 |
| 147 | MP0003795_abnormal_bone_structure | 0.70143153 |
| 148 | MP0001849_ear_inflammation | 0.69523862 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormal respiratory epithelium morphology (HP:0012253) | 9.32493407 |
| 2 | Abnormal respiratory motile cilium morphology (HP:0005938) | 9.32493407 |
| 3 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 9.25987508 |
| 4 | Absent/shortened dynein arms (HP:0200106) | 9.25987508 |
| 5 | Abnormal respiratory motile cilium physiology (HP:0012261) | 9.10990719 |
| 6 | Abnormal ciliary motility (HP:0012262) | 8.99638665 |
| 7 | Rhinitis (HP:0012384) | 8.35534109 |
| 8 | Nasal polyposis (HP:0100582) | 6.74299088 |
| 9 | Bronchiectasis (HP:0002110) | 6.30840729 |
| 10 | Chronic bronchitis (HP:0004469) | 6.15186722 |
| 11 | Abnormality of the nasal mucosa (HP:0000433) | 5.77780867 |
| 12 | Epiphyseal dysplasia (HP:0002656) | 4.58663270 |
| 13 | Metabolic alkalosis (HP:0200114) | 4.37477189 |
| 14 | Recurrent sinusitis (HP:0011108) | 4.18320174 |
| 15 | Bronchitis (HP:0012387) | 3.97138310 |
| 16 | Poikilocytosis (HP:0004447) | 3.96017857 |
| 17 | Hypokalemic alkalosis (HP:0001949) | 3.88753373 |
| 18 | Chronic sinusitis (HP:0011109) | 3.81610864 |
| 19 | Recurrent otitis media (HP:0000403) | 3.59538732 |
| 20 | Increased circulating renin level (HP:0000848) | 3.54089583 |
| 21 | Metaphyseal cupping (HP:0003021) | 3.52724473 |
| 22 | Male infertility (HP:0003251) | 3.41495788 |
| 23 | Infertility (HP:0000789) | 3.41305787 |
| 24 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.40615409 |
| 25 | Chronic otitis media (HP:0000389) | 3.34308149 |
| 26 | Irregular epiphyses (HP:0010582) | 3.28521509 |
| 27 | Abnormality of proline metabolism (HP:0010907) | 3.25642537 |
| 28 | Hydroxyprolinuria (HP:0003080) | 3.25642537 |
| 29 | Cupped ribs (HP:0000887) | 3.23294889 |
| 30 | Hyperglycinuria (HP:0003108) | 3.13237180 |
| 31 | Myositis (HP:0100614) | 3.12681841 |
| 32 | Renal tubular acidosis (HP:0001947) | 3.09809274 |
| 33 | Abnormal urine output (HP:0012590) | 3.09351904 |
| 34 | Metaphyseal dysplasia (HP:0100255) | 3.09214202 |
| 35 | Eczematoid dermatitis (HP:0000976) | 3.09051835 |
| 36 | Diaphragmatic weakness (HP:0009113) | 3.08427205 |
| 37 | Abnormality of chloride homeostasis (HP:0011422) | 3.06898763 |
| 38 | Hypomagnesemia (HP:0002917) | 3.06537967 |
| 39 | Abnormal tarsal ossification (HP:0008369) | 3.03771244 |
| 40 | Polyuria (HP:0000103) | 2.97833574 |
| 41 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.95029477 |
| 42 | Confusion (HP:0001289) | 2.92259669 |
| 43 | Delayed epiphyseal ossification (HP:0002663) | 2.91098531 |
| 44 | Hyperactive renin-angiotensin system (HP:0000841) | 2.79103604 |
| 45 | Reticulocytosis (HP:0001923) | 2.78548489 |
| 46 | Abnormality of renal excretion (HP:0011036) | 2.78263748 |
| 47 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.76556428 |
| 48 | Onycholysis (HP:0001806) | 2.76264801 |
| 49 | Recurrent abscess formation (HP:0002722) | 2.71503517 |
| 50 | Genu varum (HP:0002970) | 2.70557186 |
| 51 | Atelectasis (HP:0100750) | 2.67353802 |
| 52 | Small epiphyses (HP:0010585) | 2.67031498 |
| 53 | Acanthocytosis (HP:0001927) | 2.67006916 |
| 54 | Vacuolated lymphocytes (HP:0001922) | 2.66451337 |
| 55 | Abnormality of magnesium homeostasis (HP:0004921) | 2.64294144 |
| 56 | Recurrent bacterial skin infections (HP:0005406) | 2.60097024 |
| 57 | Orchitis (HP:0100796) | 2.59662188 |
| 58 | Gout (HP:0001997) | 2.57328326 |
| 59 | Increased cerebral lipofuscin (HP:0011813) | 2.53440181 |
| 60 | Autoimmune thrombocytopenia (HP:0001973) | 2.49762001 |
| 61 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.49421500 |
| 62 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.48977953 |
| 63 | Recurrent bronchitis (HP:0002837) | 2.47230028 |
| 64 | Abnormality of macrophages (HP:0004311) | 2.47170640 |
| 65 | Hyperbilirubinemia (HP:0002904) | 2.45658416 |
| 66 | Occipital encephalocele (HP:0002085) | 2.45532810 |
| 67 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.44859054 |
| 68 | Abnormality of glycine metabolism (HP:0010895) | 2.44859054 |
| 69 | Metaphyseal irregularity (HP:0003025) | 2.41363145 |
| 70 | Retrobulbar optic neuritis (HP:0100654) | 2.37252999 |
| 71 | Optic neuritis (HP:0100653) | 2.37252999 |
| 72 | Vitreoretinal degeneration (HP:0000655) | 2.36943279 |
| 73 | Alkalosis (HP:0001948) | 2.35780849 |
| 74 | Diplopia (HP:0000651) | 2.34229989 |
| 75 | Abnormality of binocular vision (HP:0011514) | 2.34229989 |
| 76 | Abnormality of purine metabolism (HP:0004352) | 2.33536007 |
| 77 | Flat acetabular roof (HP:0003180) | 2.31705537 |
| 78 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.31217145 |
| 79 | Abnormal drinking behavior (HP:0030082) | 2.28186286 |
| 80 | Polydipsia (HP:0001959) | 2.28186286 |
| 81 | Protuberant abdomen (HP:0001538) | 2.27311676 |
| 82 | Neonatal short-limb short stature (HP:0008921) | 2.26604010 |
| 83 | Xanthomatosis (HP:0000991) | 2.24222445 |
| 84 | Urticaria (HP:0001025) | 2.22928900 |
| 85 | Abnormality of the vertebral endplates (HP:0005106) | 2.22840483 |
| 86 | Hyperaldosteronism (HP:0000859) | 2.21973005 |
| 87 | Hypochromic microcytic anemia (HP:0004840) | 2.21908737 |
| 88 | Ketoacidosis (HP:0001993) | 2.21844771 |
| 89 | Tetany (HP:0001281) | 2.18024308 |
| 90 | Cholelithiasis (HP:0001081) | 2.16528638 |
| 91 | Absent frontal sinuses (HP:0002688) | 2.12509627 |
| 92 | Abnormality of the axillary hair (HP:0100134) | 2.11677749 |
| 93 | Abnormality of secondary sexual hair (HP:0009888) | 2.11677749 |
| 94 | Paralysis (HP:0003470) | 2.08351645 |
| 95 | Obstructive lung disease (HP:0006536) | 2.08326114 |
| 96 | Chronic obstructive pulmonary disease (HP:0006510) | 2.08326114 |
| 97 | Vascular calcification (HP:0004934) | 2.05144584 |
| 98 | Proximal tubulopathy (HP:0000114) | 2.04774497 |
| 99 | Pathologic fracture (HP:0002756) | 2.04687233 |
| 100 | Abnormal foot bone ossification (HP:0010675) | 2.04455070 |
| 101 | Flared metaphyses (HP:0003015) | 2.03838078 |
| 102 | Irregular vertebral endplates (HP:0003301) | 2.03752906 |
| 103 | Axonal loss (HP:0003447) | 2.00019614 |
| 104 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 10.3359377 |
| 105 | Stomatitis (HP:0010280) | 1.99386908 |
| 106 | Hypertriglyceridemia (HP:0002155) | 1.98925642 |
| 107 | Abnormal gallbladder morphology (HP:0012437) | 1.98615613 |
| 108 | Abnormality of renin-angiotensin system (HP:0000847) | 1.98610461 |
| 109 | Coxa vara (HP:0002812) | 1.97328270 |
| 110 | True hermaphroditism (HP:0010459) | 1.96508454 |
| 111 | Abnormality of reticulocytes (HP:0004312) | 1.96402560 |
| 112 | Pancreatic fibrosis (HP:0100732) | 1.96019533 |
| 113 | Renal salt wasting (HP:0000127) | 1.95025412 |
| 114 | Ketosis (HP:0001946) | 1.94944755 |
| 115 | Increased purine levels (HP:0004368) | 1.93625171 |
| 116 | Hyperuricemia (HP:0002149) | 1.93625171 |
| 117 | Ovoid vertebral bodies (HP:0003300) | 1.92120699 |
| 118 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.91784494 |
| 119 | Aplasia involving bones of the extremities (HP:0009825) | 1.91673630 |
| 120 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.91673630 |
| 121 | Aplasia of the phalanges of the hand (HP:0009802) | 1.91673630 |
| 122 | Hemiplegia (HP:0002301) | 1.91643592 |
| 123 | Flat capital femoral epiphysis (HP:0003370) | 1.90290099 |
| 124 | Ileus (HP:0002595) | 1.89638537 |
| 125 | Gastrointestinal infarctions (HP:0005244) | 1.89456327 |
| 126 | Muscle fiber splitting (HP:0003555) | 1.87057630 |
| 127 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.86800955 |
| 128 | Mucopolysacchariduria (HP:0008155) | 1.86800955 |
| 129 | Short femoral neck (HP:0100864) | 1.83169570 |
| 130 | Nausea (HP:0002018) | 1.82832001 |
| 131 | Recurrent skin infections (HP:0001581) | 1.82736203 |
| 132 | Mediastinal lymphadenopathy (HP:0100721) | 1.82198710 |
| 133 | Osteoarthritis (HP:0002758) | 1.80977533 |
| 134 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.80153493 |
| 135 | Plantar hyperkeratosis (HP:0007556) | 1.79054243 |
| 136 | Abnormality of the lumbar spine (HP:0100712) | 1.77879418 |
| 137 | Generalized aminoaciduria (HP:0002909) | 1.77714967 |
| 138 | Gingivitis (HP:0000230) | 1.76975324 |
| 139 | Cystic liver disease (HP:0006706) | 1.73003898 |
| 140 | Recurrent fungal infections (HP:0002841) | 1.72342498 |
| 141 | Increased serum ferritin (HP:0003281) | 1.71660606 |
| 142 | Amyloidosis (HP:0011034) | 1.71390043 |
| 143 | Keratoconjunctivitis sicca (HP:0001097) | 1.70023363 |
| 144 | Microcytic anemia (HP:0001935) | 1.66769938 |
| 145 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.64183381 |
| 146 | Hypochromic anemia (HP:0001931) | 1.62470859 |
| 147 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 1.59977108 |
| 148 | Arterial thrombosis (HP:0004420) | 1.59804374 |
| 149 | Meningitis (HP:0001287) | 1.59206295 |
| 150 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.56956671 |
| 151 | Vasculitis (HP:0002633) | 1.55792164 |
| 152 | Abnormality of iron homeostasis (HP:0011031) | 1.54460468 |
| 153 | Spontaneous hematomas (HP:0007420) | 1.52883145 |
| 154 | Polycythemia (HP:0001901) | 1.52081125 |
| 155 | Abnormality of the frontal sinuses (HP:0002687) | 1.51137193 |
| 156 | Keratoconjunctivitis (HP:0001096) | 1.50561530 |
| 157 | Nephropathy (HP:0000112) | 1.49970160 |
| 158 | Prolonged bleeding time (HP:0003010) | 1.49936761 |
| 159 | Peritonitis (HP:0002586) | 1.48521636 |
| 160 | Recurrent cutaneous fungal infections (HP:0011370) | 1.48001549 |
| 161 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.48001549 |
| 162 | Bell-shaped thorax (HP:0001591) | 1.47194015 |
| 163 | Pulmonary infiltrates (HP:0002113) | 1.47131067 |
| 164 | Malnutrition (HP:0004395) | 1.45148512 |
| 165 | Pancreatic cysts (HP:0001737) | 1.42911546 |
| 166 | Episodic fever (HP:0001954) | 1.42408400 |
| 167 | Tubulointerstitial nephritis (HP:0001970) | 1.41239906 |
| 168 | Increased IgE level (HP:0003212) | 1.39899084 |
| 169 | Recurrent pneumonia (HP:0006532) | 1.39273780 |
| 170 | Interstitial pulmonary disease (HP:0006530) | 1.39259260 |
| 171 | Purpura (HP:0000979) | 1.39145147 |
| 172 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.39086673 |
| 173 | Encephalitis (HP:0002383) | 1.38982791 |
| 174 | Obstructive sleep apnea (HP:0002870) | 1.37966395 |
| 175 | Abnormality of midbrain morphology (HP:0002418) | 1.37728525 |
| 176 | Molar tooth sign on MRI (HP:0002419) | 1.37728525 |
| 177 | Pulmonary embolism (HP:0002204) | 1.37531016 |
| 178 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.36552146 |
| 179 | Chronic hepatic failure (HP:0100626) | 1.36179182 |
| 180 | Anorexia (HP:0002039) | 1.35457326 |
| 181 | Hemoptysis (HP:0002105) | 1.34964786 |
| 182 | Ventricular fibrillation (HP:0001663) | 1.34264790 |
| 183 | Epistaxis (HP:0000421) | 1.34132150 |
| 184 | Short nail (HP:0001799) | 1.33571712 |
| 185 | Gangrene (HP:0100758) | 1.33068370 |
| 186 | Chest pain (HP:0100749) | 1.32577725 |
| 187 | Distal lower limb muscle weakness (HP:0009053) | 1.31481139 |
| 188 | Hyperkalemia (HP:0002153) | 1.31134163 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAPK15 | 5.20052549 |
| 2 | MST1R | 4.31682163 |
| 3 | MAP3K3 | 2.93835540 |
| 4 | OXSR1 | 2.72359095 |
| 5 | CSK | 2.55090729 |
| 6 | RIPK4 | 2.44359163 |
| 7 | WNK3 | 2.35721437 |
| 8 | WNK4 | 2.27715239 |
| 9 | STK24 | 2.18166063 |
| 10 | MUSK | 2.15102035 |
| 11 | MAP3K14 | 2.11189287 |
| 12 | TRPM7 | 2.07312989 |
| 13 | MST4 | 2.07238851 |
| 14 | PBK | 2.03358954 |
| 15 | RIPK1 | 2.03109994 |
| 16 | ERN1 | 2.02420849 |
| 17 | IRAK3 | 1.89257762 |
| 18 | ZAP70 | 1.86318219 |
| 19 | TRIB3 | 1.80358015 |
| 20 | LMTK2 | 1.79514777 |
| 21 | PRPF4B | 1.78321340 |
| 22 | EPHA2 | 1.74197290 |
| 23 | TBK1 | 1.72941329 |
| 24 | TYK2 | 1.70028569 |
| 25 | ERBB3 | 1.64368745 |
| 26 | WNK1 | 1.60432382 |
| 27 | ABL2 | 1.52471084 |
| 28 | PTK2B | 1.52399474 |
| 29 | MAP3K12 | 1.47535304 |
| 30 | PIM2 | 1.45048993 |
| 31 | MAP4K1 | 1.44795839 |
| 32 | JAK2 | 1.44135678 |
| 33 | NTRK2 | 1.43176107 |
| 34 | PRKG2 | 1.41988627 |
| 35 | TAOK2 | 1.41222244 |
| 36 | FES | 1.40245491 |
| 37 | CAMKK2 | 1.37362557 |
| 38 | SIK1 | 1.34731572 |
| 39 | MAP3K6 | 1.33410442 |
| 40 | BLK | 1.33286797 |
| 41 | IKBKE | 1.31747330 |
| 42 | TNIK | 1.27590758 |
| 43 | MAP3K11 | 1.26861226 |
| 44 | SMG1 | 1.26203520 |
| 45 | MAPK12 | 1.25006346 |
| 46 | MAPKAPK3 | 1.24717254 |
| 47 | MAP2K3 | 1.23471503 |
| 48 | SGK3 | 1.23023301 |
| 49 | EPHB1 | 1.20503771 |
| 50 | JAK1 | 1.19283932 |
| 51 | SGK2 | 1.18881049 |
| 52 | BMX | 1.14452143 |
| 53 | TAOK1 | 1.13895742 |
| 54 | PTK6 | 1.12833147 |
| 55 | FGR | 1.11362768 |
| 56 | LRRK2 | 1.11064307 |
| 57 | IRAK4 | 1.08536244 |
| 58 | STK10 | 1.06833532 |
| 59 | IRAK1 | 1.05543861 |
| 60 | KSR2 | 1.04711551 |
| 61 | IKBKB | 1.04353807 |
| 62 | SGK223 | 1.03773988 |
| 63 | SGK494 | 1.03773988 |
| 64 | MARK2 | 1.02099380 |
| 65 | TNK2 | 1.00163873 |
| 66 | TESK2 | 0.97059666 |
| 67 | KIT | 0.96035285 |
| 68 | PIM1 | 0.95072144 |
| 69 | GRK6 | 0.93509210 |
| 70 | STK38 | 0.90009868 |
| 71 | MAP3K7 | 0.87973113 |
| 72 | SGK1 | 0.85903308 |
| 73 | MATK | 0.85639797 |
| 74 | EIF2AK2 | 0.84672941 |
| 75 | MAPK11 | 0.83556620 |
| 76 | IRAK2 | 0.83541900 |
| 77 | PRKCD | 0.82594905 |
| 78 | CDK6 | 0.81431809 |
| 79 | MARK3 | 0.77283655 |
| 80 | MAP3K1 | 0.75939785 |
| 81 | MAP3K13 | 0.74770022 |
| 82 | HIPK2 | 0.73266885 |
| 83 | MAPK4 | 0.70839296 |
| 84 | PRKACG | 0.70539326 |
| 85 | EIF2AK3 | 0.70338150 |
| 86 | CDC42BPA | 0.69298356 |
| 87 | MAP2K4 | 0.68979369 |
| 88 | BTK | 0.68923739 |
| 89 | SYK | 0.67572134 |
| 90 | NME1 | 0.66364234 |
| 91 | PRKAA2 | 0.65496150 |
| 92 | EPHA3 | 0.64462899 |
| 93 | DDR2 | 0.63623117 |
| 94 | CAMK1D | 0.63562078 |
| 95 | PDPK1 | 0.63487102 |
| 96 | MAPKAPK5 | 0.63063075 |
| 97 | STK4 | 0.61567571 |
| 98 | SIK2 | 0.61102963 |
| 99 | PDK1 | 0.60519083 |
| 100 | ABL1 | 0.60404734 |
| 101 | PRKD2 | 0.59739852 |
| 102 | TXK | 0.59270757 |
| 103 | PRKAA1 | 0.59256501 |
| 104 | GRK5 | 0.59036351 |
| 105 | ICK | 0.58453331 |
| 106 | MET | 0.58338181 |
| 107 | MAP3K2 | 0.54111760 |
| 108 | DYRK1A | 0.53292442 |
| 109 | TLK1 | 0.53148086 |
| 110 | LYN | 0.52639267 |
| 111 | TAOK3 | 0.52084980 |
| 112 | RET | 0.50818671 |
| 113 | LCK | 0.50331377 |
| 114 | TEC | 0.48849655 |
| 115 | GSK3A | 0.48319823 |
| 116 | RAF1 | 0.47776423 |
| 117 | PIK3CG | 0.46738424 |
| 118 | MAP2K6 | 0.46526138 |
| 119 | DAPK2 | 0.46406969 |
| 120 | MAP3K5 | 0.46049724 |
| 121 | PRKCA | 0.45933714 |
| 122 | YES1 | 0.45531335 |
| 123 | GRK7 | 0.44822964 |
| 124 | CLK1 | 0.42166132 |
| 125 | FYN | 0.42038521 |
| 126 | DYRK1B | 0.41786873 |
| 127 | TGFBR2 | 0.41589187 |
| 128 | PHKG1 | 0.41119205 |
| 129 | PHKG2 | 0.41119205 |
| 130 | NME2 | 0.40406054 |
| 131 | RPS6KL1 | 0.39752196 |
| 132 | RPS6KC1 | 0.39752196 |
| 133 | PRKCQ | 0.38237040 |
| 134 | CSF1R | 0.37504740 |
| 135 | CAMKK1 | 0.36906432 |
| 136 | MAP3K8 | 0.36825154 |
| 137 | FGFR3 | 0.36283909 |
| 138 | JAK3 | 0.35570082 |
| 139 | HCK | 0.34391333 |
| 140 | NEK9 | 0.33476059 |
| 141 | NEK6 | 0.33396343 |
| 142 | PRKG1 | 0.33145704 |
| 143 | PAK4 | 0.33130583 |
| 144 | RPS6KA2 | 0.32898625 |
| 145 | ADRBK1 | 0.32783610 |
| 146 | BMPR2 | 0.31362191 |
| 147 | MOS | 0.30703214 |
| 148 | TESK1 | 0.30474321 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 4.23730630 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.22223844 |
| 3 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 2.41784933 |
| 4 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.02372988 |
| 5 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.00403523 |
| 6 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.93244026 |
| 7 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.91951740 |
| 8 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.88334093 |
| 9 | Bile secretion_Homo sapiens_hsa04976 | 1.84453818 |
| 10 | Mineral absorption_Homo sapiens_hsa04978 | 1.77830627 |
| 11 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.70417567 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.70202193 |
| 13 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.70192320 |
| 14 | Peroxisome_Homo sapiens_hsa04146 | 1.61362604 |
| 15 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.61056937 |
| 16 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.58975812 |
| 17 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.54481750 |
| 18 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.53531681 |
| 19 | Other glycan degradation_Homo sapiens_hsa00511 | 1.52547776 |
| 20 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.50423170 |
| 21 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.50342660 |
| 22 | Allograft rejection_Homo sapiens_hsa05330 | 1.47445898 |
| 23 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.46462421 |
| 24 | Influenza A_Homo sapiens_hsa05164 | 1.44042572 |
| 25 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.43282038 |
| 26 | Lysosome_Homo sapiens_hsa04142 | 1.43244833 |
| 27 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.43042956 |
| 28 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.41490524 |
| 29 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.40826436 |
| 30 | Malaria_Homo sapiens_hsa05144 | 1.40181670 |
| 31 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.39779282 |
| 32 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.39065142 |
| 33 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.36404149 |
| 34 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.36361244 |
| 35 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.36185861 |
| 36 | Measles_Homo sapiens_hsa05162 | 1.35570381 |
| 37 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.34797744 |
| 38 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.34063400 |
| 39 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.32616124 |
| 40 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.32386563 |
| 41 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.31830520 |
| 42 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.27771550 |
| 43 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.27638917 |
| 44 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.25483694 |
| 45 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.24282303 |
| 46 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.21801297 |
| 47 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.19723083 |
| 48 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.18651875 |
| 49 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.16086582 |
| 50 | Salmonella infection_Homo sapiens_hsa05132 | 1.15947528 |
| 51 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.15873778 |
| 52 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.14211122 |
| 53 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.13745379 |
| 54 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.13117789 |
| 55 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.12922309 |
| 56 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.11319226 |
| 57 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.11061791 |
| 58 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.09987821 |
| 59 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.09900779 |
| 60 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.09644981 |
| 61 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.09177470 |
| 62 | ABC transporters_Homo sapiens_hsa02010 | 1.08905784 |
| 63 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.07151577 |
| 64 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.06800569 |
| 65 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.05968064 |
| 66 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.04828773 |
| 67 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.04551517 |
| 68 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.02469553 |
| 69 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.02130293 |
| 70 | Phagosome_Homo sapiens_hsa04145 | 1.01232163 |
| 71 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.99465638 |
| 72 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.99402853 |
| 73 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.99288515 |
| 74 | Leishmaniasis_Homo sapiens_hsa05140 | 0.99020529 |
| 75 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.97919509 |
| 76 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.95658811 |
| 77 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.94978930 |
| 78 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.93479088 |
| 79 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.93306525 |
| 80 | Apoptosis_Homo sapiens_hsa04210 | 0.93272433 |
| 81 | Hepatitis B_Homo sapiens_hsa05161 | 0.92827583 |
| 82 | Asthma_Homo sapiens_hsa05310 | 0.90799691 |
| 83 | Salivary secretion_Homo sapiens_hsa04970 | 0.85946422 |
| 84 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.85907679 |
| 85 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.84573157 |
| 86 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.82235913 |
| 87 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.81928907 |
| 88 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.80534572 |
| 89 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.79688099 |
| 90 | Histidine metabolism_Homo sapiens_hsa00340 | 0.79396365 |
| 91 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.79253929 |
| 92 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.79247111 |
| 93 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.78203874 |
| 94 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.77613115 |
| 95 | Viral myocarditis_Homo sapiens_hsa05416 | 0.76133948 |
| 96 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.76123750 |
| 97 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.75164841 |
| 98 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.74635256 |
| 99 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.74304887 |
| 100 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.73364376 |
| 101 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.72572866 |
| 102 | Tuberculosis_Homo sapiens_hsa05152 | 0.72559966 |
| 103 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.72417522 |
| 104 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.71898329 |
| 105 | Shigellosis_Homo sapiens_hsa05131 | 0.70507261 |
| 106 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.69876908 |
| 107 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.69669520 |
| 108 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.69412810 |
| 109 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.66721443 |
| 110 | Platelet activation_Homo sapiens_hsa04611 | 0.66611090 |
| 111 | Endocytosis_Homo sapiens_hsa04144 | 0.66239436 |
| 112 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.66207389 |
| 113 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.64058825 |
| 114 | Carbon metabolism_Homo sapiens_hsa01200 | 0.63892919 |
| 115 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.63282692 |
| 116 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.62247826 |
| 117 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.61921611 |
| 118 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.61843353 |
| 119 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.61842229 |
| 120 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.60916157 |
| 121 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.60622797 |
| 122 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.60355712 |
| 123 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.59160803 |
| 124 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.59138016 |
| 125 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.57953457 |
| 126 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.56982041 |
| 127 | Insulin resistance_Homo sapiens_hsa04931 | 0.56726113 |
| 128 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.55706848 |
| 129 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.55486746 |
| 130 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.54064001 |
| 131 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.53698608 |
| 132 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.53443423 |
| 133 | Bladder cancer_Homo sapiens_hsa05219 | 0.52073196 |
| 134 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.51617077 |
| 135 | Endometrial cancer_Homo sapiens_hsa05213 | 0.50858179 |
| 136 | Lysine degradation_Homo sapiens_hsa00310 | 0.49185247 |
| 137 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.48947022 |
| 138 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.48012285 |
| 139 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.46979424 |
| 140 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.46678238 |
| 141 | Renin secretion_Homo sapiens_hsa04924 | 0.46362860 |
| 142 | Long-term depression_Homo sapiens_hsa04730 | 0.46187837 |
| 143 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.45767764 |
| 144 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.44612472 |
| 145 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.44263092 |
| 146 | Amoebiasis_Homo sapiens_hsa05146 | 0.43812375 |
| 147 | Nicotine addiction_Homo sapiens_hsa05033 | 0.41958699 |
| 148 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.41460221 |
| 149 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.41174397 |
| 150 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.40498358 |
| 151 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.40157612 |
| 152 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.39635000 |
| 153 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.39472130 |
| 154 | Galactose metabolism_Homo sapiens_hsa00052 | 0.38543200 |
| 155 | Sulfur relay system_Homo sapiens_hsa04122 | 0.37342057 |
| 156 | Hepatitis C_Homo sapiens_hsa05160 | 0.37186254 |
| 157 | Pertussis_Homo sapiens_hsa05133 | 0.37000613 |
| 158 | Legionellosis_Homo sapiens_hsa05134 | 0.33083759 |
| 159 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.32526577 |
| 160 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.31297957 |

